An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the pilot stage as an effort to incentivize pharma manufacturers to achieve a more mature state of quality culture.
Sarah Akers
Advertisement
Consultant, Shabas Solutions LLC
Articles by Sarah Akers
Advertisement
Latest Updated Articles
Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for ExecutivesPublished: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Bob Mauch: Strengthening the Chain
2
Novo Nordisk Stock Reacts to Recent Board Changes
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
